Johnson & Johnson (JNJ)
272.00
+4.86
(+1.82%)
USD |
NYSE |
Nov 20, 10:11
Johnson & Johnson Free Cash Flow : 19.98B for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 19.98B |
| June 30, 2026 | 22.61B |
| March 31, 2026 | 17.80B |
| December 31, 2025 | 19.70B |
| September 30, 2025 | 20.46B |
| June 30, 2025 | 18.18B |
| March 31, 2025 | 20.36B |
| December 31, 2024 | 19.84B |
| September 30, 2024 | 19.50B |
| June 30, 2024 | 20.30B |
| March 31, 2024 | 18.70B |
| December 31, 2023 | 18.25B |
| September 30, 2023 | 15.74B |
| June 30, 2023 | 14.55B |
| March 31, 2023 | 16.21B |
| December 31, 2022 | 17.18B |
| September 30, 2022 | 17.74B |
| June 30, 2022 | 19.95B |
| March 31, 2022 | 19.73B |
| December 31, 2021 | 19.76B |
| September 30, 2021 | 22.46B |
| June 30, 2021 | 22.56B |
| March 31, 2021 | 20.85B |
| December 31, 2020 | 20.19B |
| September 30, 2020 | 18.31B |
| Date | Value |
|---|---|
| June 30, 2020 | 17.44B |
| March 31, 2020 | 19.76B |
| December 31, 2019 | 19.92B |
| September 30, 2019 | 19.71B |
| June 30, 2019 | 18.38B |
| March 31, 2019 | 18.47B |
| December 31, 2018 | 18.53B |
| September 30, 2018 | 18.47B |
| June 30, 2018 | 18.49B |
| March 31, 2018 | 18.37B |
| December 31, 2017 | 17.78B |
| September 30, 2017 | 18.47B |
| June 30, 2017 | 17.62B |
| March 31, 2017 | 16.34B |
| December 31, 2016 | 15.54B |
| September 30, 2016 | 13.70B |
| June 30, 2016 | 14.41B |
| March 31, 2016 | 15.04B |
| December 31, 2015 | 15.82B |
| September 30, 2015 | 14.97B |
| June 30, 2015 | 13.54B |
| March 31, 2015 | 13.79B |
| December 31, 2014 | 14.76B |
| September 30, 2014 | 14.60B |
| June 30, 2014 | 15.83B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 11.69B |
| Merck & Co., Inc. | 14.75B |
| Pfizer Inc. | 11.79B |
| Bristol Myers Squibb Co. | 9.286B |
| Abbott Laboratories | 6.757B |